Related Experiment Videos
Epidemiology and pathogenesis of scleroderma.
Keng Chen1, Adrian See, Stephen Shumack
1The St George Hospital, Kogarah, New South Wales, Australia. kengchen74@hotmail.com
The Australasian Journal of Dermatology
|February 13, 2003
Summary
Scleroderma is a connective tissue disease causing skin fibrosis and potentially organ damage. Research suggests environmental, genetic, and immune factors, including microchimerism, contribute to its development.
Area of Science:
- Rheumatology
- Immunology
- Genetics
Background:
- Scleroderma is a complex connective tissue disorder.
- It involves skin fibrosis and can affect internal organs.
- The exact cause is unknown but involves genetic and environmental factors.
Purpose of the Study:
- To review the epidemiology of scleroderma.
- To discuss the pathogenesis of scleroderma.
- To highlight microchimerism as a potential risk factor.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of research on scleroderma pathogenesis.
- Focus on microchimerism research.
Main Results:
- Scleroderma etiology involves genetic and environmental factors.
- Immune system, vascular, and extracellular matrix abnormalities are observed.
- Microchimerism is an emerging area of research for scleroderma risk.
Conclusions:
- Scleroderma is a multifactorial disease.
- Understanding pathogenesis is key to identifying risk factors like microchimerism.
- Further research is needed to elucidate the role of microchimerism.